Vaccine ETFs - There are two ETFs named Vaccine ETF, one managed by Guotai Fund tracking the Guozheng Vaccine and Biotechnology Index, consisting of 50 companies in the biotechnology sector with an average market capitalization of approximately 54.5 billion CNY [1] - The second Vaccine ETF is managed by Harvest Fund, tracking the CSI Vaccine and Biotechnology Index, which includes up to 50 companies involved in vaccine research and production, with 43 constituent stocks and an average market capitalization of about 20.5 billion CNY [2] - The overlap between the two indices includes 19 common stocks, with 31 unique to the Guozheng index and 24 unique to the CSI index [3] - The historical performance shows that the CSI Vaccine and Biotechnology Index has outperformed the Guozheng index in annualized returns over the past year, three years, and five years, although both indices have negative returns over the last three and five years [5] - The CSI index has a higher annualized volatility compared to the Guozheng index [5] Satellite ETFs - There are two ETFs named Satellite ETF, one managed by Yongying Fund tracking the Guozheng Commercial Satellite Communication Industry Index, which includes 50 companies with an average market capitalization of approximately 38.6 billion CNY [9] - The second Satellite ETF is managed by Fortune Fund, tracking the CSI Satellite Industry Index, which also consists of 50 companies with an average market capitalization of about 26.6 billion CNY [10] - Both indices share 28 common stocks, with each having 22 unique stocks [11] - The Guozheng Commercial Satellite Communication Industry Index has outperformed the CSI Satellite Industry Index in annualized returns over the past year and three years, while the CSI index has outperformed in the five-year period [12][13] - The annualized volatility of both indices is relatively similar across one, three, and five years [13] - The valuation levels indicate that the Guozheng index's TTM P/E ratio is at the historical 100th percentile, while the CSI index's TTM P/E ratio is above the 90th percentile [15][17]

Group 1: Consumer Electronics ETF - There are two ETFs named Consumer Electronics ETF, one managed by Huaxia Fund tracking the Guozheng Consumer Electronics Theme Index, and the other managed by Ping An Fund tracking the Zhongzheng Consumer Electronics Theme Index [2][3] - The Guozheng Consumer Electronics Theme Index consists of 50 listed companies involved in the consumer electronics industry, with an average market capitalization of approximately 664 million [2][4] - The Zhongzheng Consumer Electronics Theme Index also includes 50 companies, but with a higher average market capitalization of about 1,222 million [4] - Both indices share 29 common constituent stocks, while each has 21 unique stocks [5] - The Zhongzheng Consumer Electronics Theme Index has outperformed the Guozheng index in terms of returns over the past one, three, and five years, although it also exhibits higher annualized volatility [7][8] - The current P/E ratio of the Guozheng index is around the 55th percentile of the past ten years, indicating a medium level, while the Zhongzheng index is at the 90th percentile, suggesting a high valuation [8] Group 2: Technology Leaders ETF - There are two ETFs named Technology Leaders ETF, with one managed by Huitianfu Fund tracking the Zhongzheng Huagangshen Technology Leaders Index, and the other managed by ICBC Credit Suisse Fund tracking the Zhongzheng Technology Leaders Index [11][12] - The Zhongzheng Huagangshen Technology Leaders Index includes 50 large-cap companies with significant market share and R&D investment, with an average market capitalization of approximately 2,399 million [11] - The Zhongzheng Technology Leaders Index also consists of 50 companies but has a lower average market capitalization of about 924 million [13] - Both indices share 23 common constituent stocks, with each having 27 unique stocks [14] - The Zhongzheng Technology Leaders Index has outperformed the Zhongzheng Huagangshen index in returns over the past one, three, and five years, but it also has higher volatility [16] - The current P/E ratio of the Zhongzheng Huagangshen index is below the 25th percentile of the past ten years, while the Zhongzheng Technology Leaders index is above the 70th percentile, indicating a relatively high valuation [17]

Group 1: Biovaccine ETFs - There are two ETFs named Biovaccine ETF, one managed by Penghua Fund tracking the Guozhen Vaccine and Biotechnology Index, consisting of 50 companies with an average market capitalization of approximately 53.9 billion yuan [1][3] - The second Biovaccine ETF is managed by Harvest Fund, tracking the Zhongzheng Vaccine and Biotechnology Index, which includes up to 50 companies involved in vaccine research and production, with an average market capitalization of about 22 billion yuan [3][5] - The two indices share 19 overlapping constituent stocks, with the Guozhen index having 31 unique stocks and the Zhongzheng index having 24 unique stocks [5][6] - In terms of past performance, the Zhongzheng Vaccine and Biotechnology Index has outperformed the Guozhen index over one, three, and five years, with a notably higher increase in the past year [6][7] Group 2: Biopharmaceutical ETFs - There are two ETFs named Biopharmaceutical ETF, one managed by Tianhong Fund tracking the Guozhen Biopharmaceutical Index, which includes the top 30 companies based on market capitalization and liquidity, with an average market capitalization of around 45.2 billion yuan [11][13] - The second Biopharmaceutical ETF is managed by Guotai Fund, tracking the Zhongzheng Biopharmaceutical Index, which selects companies providing cell therapy, gene sequencing, and other biopharmaceutical services, with an average market capitalization of approximately 71.9 billion yuan [13][15] - The two indices have 18 overlapping constituent stocks, with each index having 12 unique stocks [15][16] - The Zhongzheng Biopharmaceutical Index has consistently outperformed the Guozhen index over one, three, and five years, while the Guozhen index exhibits higher annualized volatility [15][17]